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Background
Understanding the role of the multiple and complex
mechanisms of antibody mediated HIV inhibition may be
key to the rational design of antibody based vaccines. Pri-
mary macrophages and the monocyte cell line Monomac-
1 may offer an important tool for evaluation of classical
and non-classical (particularly Fc mediated) antibody
mediated neutralization of HIV.
Methods
Monocyte derived macrophages (MDMs) were isolated
from PBMCs, while Monomac-1 cells were obtained from
DSMZ. Expression of CD4, HIV-1 co-receptors and FcRs
were analysed by FACS staining. Antibody inhibition was
determined by p24 release. FcRs involvement was deter-
mined using blocking antibodies. Cytokine release was
quantified by in house multiplex bead immunoassay.
Antibody and immune-complex binding to HIV and FcRs
were assessed using an optical SPR Imager. HIV intracellu-
lar trafficking was studied by fluorescent microscopy.
Results
In spite of differences in relative HIV-1 co-receptor expres-
sion, Monomac-1 and MDM were both susceptible to
HIV-1 BaL and primary R5 isolates. However, X4 HIV-1
LAV was only able to infect Monomac-1 cells. Antibody
inhibitory activity did not correlate with antibody binding
affinity for HIV-1. Most inhibitory antibodies tested
revealed more potent activity on Monomac-1 compared
to MDM, although a few only inhibited HIV-1 infection of
MDM. The activity of some antibodies showed an FcRs
dependent mechanism of inhibition. These data were
confirmed by the analysis of immune complexes binding
affinity for FcRs, and by microscopy, which revealed a
high level of co-localization of HIV viral particles with the
endosomal marker CD63 in presence of 2F5 monoclonal
antibody. However, a second category of antibodies
appeared to work via an FcR independent mechanism
linked to the secretion of HIV inhibitory chemokines.
Conclusion
Monomac-1 cells and MDM represent a useful tool for
screening humoral responses to potential vaccine candi-
dates and for probing the complex mechanisms behind
antibody-mediated HIV-1 inhibition.
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